Literature DB >> 30156145

The Effects of Curcumin on Glycemic Control and Lipid Profiles Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Metaanalysis of Randomized Controlled Trials.

Reza Tabrizi1, Sina Vakili2, Kamran B Lankarani3, Maryam Akbari1, Naghmeh Mirhosseini4, Majid Ghayour-Mobarhan5, Gordon Ferns6, Fatemeh Karamali7, Maryam Karamali8, Mohsen Taghizadeh7, Ebrahim Kouchaki9,10, Zatollah Asemi7.   

Abstract

BACKGROUND: This systematic review and meta-analysis of randomized controlled trials (RCTs), were performed to determine the effects of curcumin intake on glycemic control and lipid profiles among patients with metabolic syndrome (MetS) and related disorders.
METHODS: We searched the following databases up until January 2018: MEDLINE, EMBASE, Web of Science, and Cochrane Central Register of Controlled Trials. The relevant data were extracted and evaluated for quality of the studies in accordance with the Cochrane risk of bias tool. Data were pooled using the inverse variance method and expressed as standardized mean difference (MDs) with 95% confidence intervals (95% CI).
RESULTS: Twenty-six trials with 1890 participants were included in the current meta-analysis. The findings demonstrated the significant association between curcumin intake and reduced fasting glucose levels (SMD -0.78; 95% CI, -1.20, -0.37; P<0.001), homeostasis model of assessment-estimated insulin resistance (SMD -0.91; 95% CI, -1.52, -0.31; P=0.003) and HbA1c (SMD -0.92; 95% CI, -1.37, -0.47; P<0.001). In addition, curcumin supplementation was significantly associated with triglyceride (SMD -1.21; 95 % CI, -1.78, -0.65; P<0.001) and total cholesterol reduction (SMD -0.73; 95 % CI, -1.32, -0.13; P= 0.01). However, curcumin intake significantly increased insulin levels (SMD 0.92; 95% CI, 0.06, 1.78; P=0.036). We found no significant effect of curcumin supplementation on LDL- (SMD -0.52; 95% CI, -1.14, 0.11; P=0.10) and HDL-cholesterol levels (SMD 0.28; 95% CI, -0.22, 0.77; P=0.27).
CONCLUSION: Overall, curcumin consumption was associated with a significant reduction in fasting glucose, HOMA-IR, HbA1c, triglycerides and total cholesterol levels among patients with MetS and related disorders, but did not affect LDL- and HDL-cholesterol levels. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Curcumin; Metabolic Syndrome (MetS); Randomized Controlled Trials (RCTs); glycemic control; lipid profiles; meta-analysis.

Mesh:

Substances:

Year:  2018        PMID: 30156145     DOI: 10.2174/1381612824666180828162053

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

1.  Renoprotective Roles of Curcumin.

Authors:  Habib Yaribeygi; Mina Maleki; Muhammed Majeed; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Curcuminoids for Metabolic Syndrome: Meta-Analysis Evidences Toward Personalized Prevention and Treatment Management.

Authors:  Agustina Dwi Retno Nurcahyanti; Fonny Cokro; Martha P Wulanjati; Mona F Mahmoud; Michael Wink; Mansour Sobeh
Journal:  Front Nutr       Date:  2022-06-09

Review 3.  Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?

Authors:  Stanisław Surma; Amirhossein Sahebkar; Jakub Urbański; Peter E Penson; Maciej Banach
Journal:  Front Nutr       Date:  2022-05-17

4.  Turmeric and Curcumin: From Traditional to Modern Medicine.

Authors:  Maryam Akaberi; Amirhossein Sahebkar; Seyed Ahmad Emami
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Curcuma Longa, the "Golden Spice" to Counteract Neuroinflammaging and Cognitive Decline-What Have We Learned and What Needs to Be Done.

Authors:  Alessandra Berry; Barbara Collacchi; Roberta Masella; Rosaria Varì; Francesca Cirulli
Journal:  Nutrients       Date:  2021-04-30       Impact factor: 5.717

6.  Effects of curcumin on glycemic control and lipid profile in prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Nalinee Poolsup; Naeti Suksomboon; Putu Dian Marani Kurnianta; Kulchalee Deawjaroen
Journal:  PLoS One       Date:  2019-04-23       Impact factor: 3.240

Review 7.  Biochemistry, Safety, Pharmacological Activities, and Clinical Applications of Turmeric: A Mechanistic Review.

Authors:  Rabia Shabir Ahmad; Muhammad Bilal Hussain; Muhammad Tauseef Sultan; Muhammad Sajid Arshad; Marwa Waheed; Mohammad Ali Shariati; Sergey Plygun; Mohammad Hashem Hashempur
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-10       Impact factor: 2.629

8.  Effects of curcumin supplementation on vitamin D levels in women with premenstrual syndrome and dysmenorrhea: a randomized controlled study.

Authors:  Leyla Arabnezhad; Mahtab Mohammadifard; Ladan Rahmani; Zahra Majidi; Gordon A Ferns; Afsane Bahrami
Journal:  BMC Complement Med Ther       Date:  2022-01-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.